{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:30:37Z","timestamp":1792161037742,"version":"4.4.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec id=\"ab-ioi240015-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Federally qualified health centers (FQHCs) deliver health care to nearly 30 million underserved persons across the US, yet nationwide and state-level breast, cervical, and colorectal cancer screening use in FQHCs is not described. Furthermore, it is unknown how the underscreened FQHC population contributes to the total underscreened population at national and state levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe national- and state-level breast, cervical, and colorectal cancer screening use among individuals served by FQHCs in the US and to estimate the percentage of underscreened individuals in the general population served by FQHCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cross-sectional analysis of cancer screening used data from January 1 through December 31, 2020, from the FQHC Uniform Data System, reported by 1364 FQHCs across the US, and self-reported estimates from the Behavioral Risk Factor Surveillance System. Participants were 16 696 692 US adults served by FQHCs who were eligible for breast (age, 50-74 years), cervical (age, 21-64 years), and colorectal (age, 50-75 years) cancer screening. Analyses were conducted between January 1 and June 30, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Breast, cervical, and colorectal cancer screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Percentages of breast, cervical, and colorectal cancer screening-eligible individuals up to date on screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3\u202f162\u202f882 breast, 7\u202f444\u202f465 cervical, and 6\u202f089\u202f345 colorectal screening\u2013eligible individuals were served by FQHCs in 2020. Nationally, screening use in FQHCs was 45.4% (95% CI, 45.4%-45.5%) for breast cancer, 51.0% (95% CI, 51.0%-51.1%) for cervical cancer, and 40.2% (95% CI, 40.1%-40.2%) for colorectal cancer. Screening use among the US general population was 78.2% (95% CI, 77.6%-78.9%) for breast cancer, 82.9% (95% CI, 82.3%-83.4%) for cervical cancer, and 72.3% (95% CI, 71.7%-72.8%) for colorectal cancer. The contribution of the underscreened population served by FQHCs to the national underscreened general population was 16.9% (95% uncertainty interval [UI], 16.4%-17.4%) for breast cancer, 29.7% (95% UI, 28.8%-30.7%) for cervical cancer, and 14.7% (95% UI, 14.4%-15.0%) for colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi240015-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Findings from this national cross-sectional study indicated major gaps in cancer screening use in FQHCs in the US. Improved prevention is urgently needed to address screening disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2024.0693","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:33:05Z","timestamp":1714390385000},"page":"671","source":"Crossref","is-referenced-by-count":53,"title":["National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers"],"prefix":"10.1001","volume":"184","author":[{"given":"Trisha L.","family":"Amboree","sequence":"first","affiliation":[{"name":"Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"Montealegre","sequence":"additional","affiliation":[{"name":"Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvita","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, Medical University of South Carolina, Charleston"},{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Damgacioglu","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, Medical University of South Carolina, Charleston"},{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Y.","family":"Chiao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, Medical University of South Carolina, Charleston"},{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyani","family":"Sonawane","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, Medical University of South Carolina, Charleston"},{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish A.","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, Medical University of South Carolina, Charleston"},{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Adsul","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque"},{"name":"Cancer Control and Population Sciences Research Program, University of New Mexico Comprehensive Cancer Center, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"ioi240015r1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"7","key":"ioi240015r2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"19","key":"ioi240015r3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"ioi240015r4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10552-023-01758-z","article-title":"Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.","volume":"34","author":"Mondrag\u00f3n M\u00e1rquez","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"5","key":"ioi240015r7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10903-012-9701-8","article-title":"Cancer screening at a federally qualified health center: a qualitative study on organizational challenges in the era of the patient-centered medical home.","volume":"15","author":"Martinez-Gutierrez","year":"2013","journal-title":"J Immigr Minor Health"},{"key":"ioi240015r8","author":"Kim","year":"2020","journal-title":"Implement Sci"},{"issue":"9","key":"ioi240015r9","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1097\/MLR.0b013e31817fdf68","article-title":"Implementing colorectal cancer screening in community health centers: addressing cancer health disparities through a regional cancer collaborative.","volume":"46","author":"Taplin","year":"2008","journal-title":"Med Care"},{"issue":"1","key":"ioi240015r15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s13187-013-0535-4","article-title":"Opportunities for improving cancer prevention at federally qualified health centers.","volume":"29","author":"Allen","year":"2014","journal-title":"J Cancer Educ"},{"issue":"23","key":"ioi240015r16","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/cncr.v125.23","article-title":"Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: opportunities for improving screening outcomes.","volume":"125","author":"Bharti","year":"2019","journal-title":"Cancer"},{"key":"ioi240015r17","author":"Choi","year":"2015","journal-title":"Am J Public Health"},{"issue":"5","key":"ioi240015r19","doi-asserted-by":"publisher","first-page":"e637","DOI":"10.1200\/OP.20.01089","article-title":"Fragmentation of care among Black women with breast cancer and comorbidities: the role of health systems.","volume":"17","author":"Doose","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"19","key":"ioi240015r24","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"ioi240015r25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaoncol.2021.0884","article-title":"Association of cancer screening deficit in the United States with the COVID-19 pandemic.","volume":"7","author":"Chen","year":"2021","journal-title":"JAMA Oncol"},{"key":"ioi240015r5","unstructured":"Health Resources & Services Administration: Bureau of Primary Health Care. What is a health center? Accessed April 24, 2023. https:\/\/bphc.hrsa.gov\/about-health-centers\/what-health-center?"},{"key":"ioi240015r6","unstructured":"Health Resources & Services Administration. National Health Center Program Uniform Data System (UDS) awardee data. Accessed April 24, 2023. https:\/\/data.hrsa.gov\/tools\/data-reporting\/program-data\/national?"},{"key":"ioi240015r10","unstructured":"Health Resources & Services Administration. Electronic reading room. Accessed March 7, 2023. https:\/\/www.hrsa.gov\/foia\/electronic-reading."},{"key":"ioi240015r11","unstructured":"Health Resources & Services Administration Bureau for Primary Care. Uniform Data System reporting instructions for 2020 health center data. Accessed January 10, 2023. https:\/\/bphc.hrsa.gov\/sites\/default\/files\/bphc\/funding\/2020-uds-manual.pdf?"},{"key":"ioi240015r12","unstructured":"Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. Behavioral Risk Factor Surveillance System: 2020 BRFSS survey data and documentation. Accessed January 10, 2023. https:\/\/www.cdc.gov\/brfss\/annual_data\/annual_2020.html?"},{"key":"ioi240015r13","unstructured":"Behavioral Risk Factor Surveillance System. Overview: BRFSS 2020. July 7, 2021. Accessed January 10, 2023. https:\/\/www.cdc.gov\/brfss\/annual_data\/2020\/pdf\/overview-2020-508.pdf?"},{"key":"ioi240015r14","unstructured":"Department of Health and Human Services: Office of Disease Prevention and Health Promotion. Healthy People 2030: Preventive care overview and objectives. Accessed November 23, 2023. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/preventive-care"},{"key":"ioi240015r18","unstructured":"The community guide: guide to community preventive services. Cancer. Updated October 4, 2022. Accessed August 21, 2023. https:\/\/www.thecommunityguide.org\/topics\/cancer.html."},{"key":"ioi240015r20","unstructured":"Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Accessed July 28, 2023. https:\/\/www.cdc.gov\/cancer\/nbccedp\/about.htm"},{"key":"ioi240015r21","unstructured":"Centers for Disease Control and Prevention. Cancer screening change packages. Accessed May 18, 2023. https:\/\/www.cdc.gov\/cancer\/dcpc\/resources\/change-packages"},{"key":"ioi240015r22","unstructured":"National Cancer Institute, Division of Cancer Control and Population Sciences: Healthcare Delivery Research Program. Cancer Moonshot efforts: Federal Cervical Cancer Collaborative. Accessed June 16, 2023. https:\/\/healthcaredelivery.cancer.gov\/cancer-moonshot"},{"key":"ioi240015r23","unstructured":"Health Resources & Services Administration. Improving cervical cancer care through federal partnerships. Accessed August 17, 2023. https:\/\/www.hrsa.gov\/office-womens-health\/improving-cervical-cancer-care"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2818024\/jamainternal_amboree_2024_oi_240015_1717424158.82962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:19:10Z","timestamp":1717413550000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2818024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.0693","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}